ChemoCentryx Inc (CCXI)
NASDAQ · Financial Services
ChemoCentryx Inc Operating Income 2018–2021
ChemoCentryx Inc annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- ChemoCentryx Inc operating income for the quarter ending March 31, 2026 was -373673, a 99.02% decrease year-over-year.
- ChemoCentryx Inc operating income for the twelve months ending March 31, 2026 was -70.2 M.
- ChemoCentryx Inc annual operating income for 2021 was -129.9 M, a 135.46% increase from 2020.
- ChemoCentryx Inc annual operating income for 2020 was -55.2 M, a 5.36% decrease from 2019.
- ChemoCentryx Inc annual operating income for 2019 was -58.3 M, a 44.78% increase from 2018.
- ChemoCentryx Inc annual operating income for 2018 was -40.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ChemoCentryx Inc Operating Income — FAQ
ChemoCentryx Inc (CCXI) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is ChemoCentryx Inc's operating income?
ChemoCentryx Inc (CCXI) reported operating income of -$130M for fiscal 2021.
Where can I see CCXI's operating income history?
The chart and table above show ChemoCentryx Inc's operating income by year and by quarter, including the growth rate.